yahoo health news


yahoo health news





date date gay sex sex
viagar
sexual health clinic glasgow
poladay system tooth whitening
san diego mortgage brokers
google pozycjonowanie stron

Medical/Pharmaceutical News

Enter symbol:
symbol lookup

(all times are US Eastern)
Friday August 3, 2007

* Javelin Pharmaceuticals to Host Quarterly Conference Call
1:40 pm - Business Wire

* Pacific Sands' Hose Filter Sales Surge on Report Exposing
Dangerous Levels of Lead in Garden Hoses
1:34 pm - Marketwire

* Glaxo says gets new order for bird flu vaccine
1:27 pm - at Reuters

* UPDATE - Plusses seen in end of Boston Scientific unit sale
1:15 pm - at Reuters

* Medifast to Announce Second Quarter Results on Thursday, August
9th
1:14 pm - PR Newswire

* GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen.
First North American Clinical Trials with GSK's Candidate
Pre-pandemic Flu Vaccine to Start.
1:04 pm - PR Newswire

* UPDATE - P&G profit up but forecast pressures shares
12:54 pm - at Reuters

* Environmentally-Friendly Lice Treatment is More Cost Effective and
Doesn't Employ Harmful Toxins
12:49 pm - PR Newswire

* Datascope names CFO
12:48 pm - at Reuters

* Health insurers' subprime exposure limited-analyst
12:46 pm - at Reuters

* Datascope Names Henry M. Scaramelli Chief Financial Officer
12:38 pm - PrimeNewswire

* Interleukin Genetics to Host Second Quarter 2007 Financial Results
Conference Call on August 9
12:38 pm - PR Newswire

* Becton confirms contamination of syringes in Poland
12:33 pm - at Reuters

* Bridge Collapse: Member of National Crisis Response Team Available
12:23 pm - Marketwire

* RPT-Luxottica seeks $2 bln loan to finance Oakley buy
12:01 pm - at Reuters

* The Yarn Texturizing, Throwing, and Twisting Mills Industry's
Revenue For the Year 2006 Was Approximately $4,640,000,000
12:00 pm - Business Wire

* S&P, Fitch cut Boston Scientific's debt to junk
11:41 am - at Reuters

* Fitch Downgrades Boston Scientific's IDR to 'BB+'; Outlook Remains
Negative
11:34 am - Business Wire

* Theratechnologies to Present at the 27th Annual Canaccord Adams
Global Growth Conference in Boston
11:30 am - Marketwire

* Sonus Pharmaceuticals Q2 loss widens
11:09 am - at Reuters

* Experts Available to Discuss Breast Cancer and Early Detection
11:02 am - Business Wire

* Sonus Pharmaceuticals Highlights Corporate Progress and Reports
Second Quarter Financial Results
11:00 am - Business Wire

* BioScrip Appoints Tom Ordemann Vice President of Community
Pharmacy Operations
10:50 am - Business Wire

* Pfizer seeks to quash Nigerian drug test report
10:44 am - at Reuters

* Chindex International, Inc. Signs Contract for First
Exim-Sponsored Medical Equipment Sale in China Under New Exim-MOF
Framework
10:43 am - PR Newswire

* Belgium Patient Monitoring Medical Equipment Market Profile
10:40 am - Business Wire

* Company Profile for Bridge Pharmaceuticals, Inc.
10:40 am - Business Wire

* 'Build-an-ID' Program a Success at Local ADA Summer Camp
10:33 am - PR Newswire

* Novo Nordisk Increased First Half-Year Operating Profit by 14% and
Raises the Expectation for 2007 Operating Profit Growth to Around
10%
10:32 am - PR Newswire

* IsoTis to Release Second Quarter 2007 Results on August 7
10:19 am - PR Newswire

* Gene Network Sciences Announces Research Collaboration With
CombinatoRx
10:17 am - PR Newswire

* Couple Launches Cross Country SuRVivor Tour to Raise Funds for
Childhood Cancer
9:52 am - Business Wire

* ORLive Presents: Off-Pump Coronary Artery Bypass -- A Beating
Heart Procedure
9:43 am - Marketwire

* Avantium Expands its Presence in the US
9:00 am - PR Newswire

* Mission Pharmacal's Citracal(R) to be Featured in Welcome Kit for
Patients Taking a New Treatment for Paget's Disease of the Bone
9:00 am - PR Newswire

* Icagen Q2 results
8:51 am - at Reuters

* MailExpress Secures $15 Million Series B Funding
8:42 am - Marketwire

* Emisphere Technologies, Inc. to Webcast Quarterly Earnings Call
8:40 am - PR Newswire

* ImmuCell Announces Financial Results for Second Quarter Of 2007
8:30 am - Marketwire

* Icagen Reports Second Quarter 2007 Financial Results
8:30 am - Business Wire

* Ophthalmic Imaging Systems Reports Second Quarter 2007 Results
8:30 am - Business Wire

* Video: Landmark Study in The Lancet: Patients Treated With
Betaseron(R) After First MS Attack Experienced Significant Delay
in MS Progression
8:30 am - PR Newswire

* Par Pharmaceutical Begins Shipment of Additional Dosage Strength
of Generic TOPROL-XL(R)
8:30 am - PR Newswire

* Novavax Announces Release Date of 2007 Second Quarter Financial
Results and Investor Conference Call
8:30 am - PR Newswire

* UPDATE - Novo Nordisk ups outlook as earnings rise
8:22 am - at Reuters

* Sciele Pharma says to buy back up to $40 mln of common shares
8:13 am - at Reuters

* Metabasis Therapeutics Q2 loss widens
8:10 am - at Reuters

* Oculus Innovative Sciences Schedules Fiscal First Quarter 2008
Financial Results Release and Conference Call
8:08 am - Business Wire

* Cavit Sciences, Inc. Announces Additional Compound Information
8:00 am - Marketwire

* Eurand Reports First Half 2007 Key Achievements and Financial
Results
8:00 am - PrimeNewswire

* Notice Campaign Begins for Ovcon 35 Consumer Settlement
8:00 am - PR Newswire

* Metabasis Therapeutics Announces Second Quarter 2007 Results and
Comments on Recent Events
8:00 am - Business Wire

* North American Scientific Will Divest NOMOS Business and Focus
Exclusively on Brachytherapy
8:00 am - Business Wire

* INNOVIVE Pharmaceuticals Reaches Agreement with FDA on Special
Protocol Assessment for Pivotal Phase II Clinical Trial with
Tamibarotene in Refractory Acute Promyelocytic Leukemia
8:00 am - Business Wire

* Unigene to Present at Canaccord Adams' 27th Global Growth
Conference
8:00 am - Business Wire

* Array BioPharma Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1
Cancer Patient Trial
8:00 am - Business Wire

* pSivida Strengthens Board with the Appointment of an Australian
based Non-executive Director
8:00 am - Business Wire

* Idera Pharmaceuticals to Present at Canaccord Adams 27th Annual
Global Growth Conference
8:00 am - Business Wire

* Sciele Pharma, Inc. Adopts $40 Million Share Repurchase Program
8:00 am - Business Wire

* KineMed Completes $15 Million Offering of Convertible Notes
7:30 am - PR Newswire

Older Headlines - Most Recent Headlines

View headlines from:

Help

---------------------------------------------------------------------


Questions or Comments?